Sec Form 3 Filing - COFFEE MICHAEL DENIS @ Adamas Pharmaceuticals Inc - 2014-04-09

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person COFFEE MICHAEL DENIS 2. Issuer Name and Ticker or Trading Symbol Adamas Pharmaceuticals Inc [ ADMS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Senior VP, Strategy & Planning (Last) (First) (Middle) C/O ADAMAS PHARMACEUTICALS, INC., 2200 POWELL ST, STE 220 3. Date of Earliest Transaction (MM/DD/YY) 04/09/2014 (Street) EMERYVILLE, CA94608 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 1.755 ( 1 ) 09/30/2019 Common Stock 36,666 D Stock Option (Right to Buy) $ 0.665 ( 2 ) 11/16/2021 Common Stock 20,000 D Stock Option (Right to Buy) $ 0.665 ( 3 ) 02/22/2022 Common Stock 8,750 D Stock Option (Right to Buy) $ 3.305 ( 4 ) 12/13/2023 Common Stock 110,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other COFFEE MICHAEL DENIS C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE, CA94608 Senior VP, Strategy & Planning Signatures /s/Danielle Naftulin, Attorney-in-Fact 04/10/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Option shares shall vest as follows: one-fourth (1/4th) of the shares vest one year after May 11, 2009; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of May 11, 2009, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting. ( 2 )The Option shares shall vest as follows: 1/8th of the shares subject to such option shall vest each month after May 30, 2011, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting. ( 3 )The Option shares shall vest as follows: 1/8th of the shares subject to such option shall vest on the last day of each fiscal quarter after March 1, 2012, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting. ( 4 )The Option shares shall vest as follows: one-fifth (1/5th) of the shares vest one year after November 27, 2013; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of November 27, 2013, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.